Search

everythinglearnresearchcommunity

for

Search:↓

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Ets2 gene is crucial for placental development in mice.

X-irradiation reduces collagen in rat skin, causing delayed skin damage.

Many patients on methotrexate experience significant side effects but still continue the medication.

Ascorbigen increases hair cell growth in a lab setting but does not prevent hair loss from chemotherapy in mice.

Citrullus colocynthis fruit extract has strong antioxidant and cancer-fighting potential.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Topical alpha-terthienyl with UVA may safely treat psoriasis without cancer risk.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Targeting specific molecular pathways may improve treatments for chemoresistant cancers.

Gamma-ray exposure can cause long-lasting damage to hair follicles, affecting hair structure and color.

UV photography can help identify people at higher risk for skin cancer, and male pattern baldness at age 45 is linked to a higher risk of certain skin cancers.

SOX4 is crucial for the development of melanoma.

LAAM caused developmental toxicity in tolerant rats without causing birth defects.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Hydroxyl radicals cause hair follicle cell death during chemotherapy by reducing Bcl-2 protein levels.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

Kenikir leaf extract nanosuspension may help inhibit breast cancer cell growth.

Pertussis toxin may contribute to hair loss in alopecia areata.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Keratin mutations may cause scarring alopecia by damaging hair structure.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

A mother's diet at conception can cause lasting genetic changes in her child.

Topical putrescine and spermine increased DNA synthesis in hairless mouse skin.

Keratin gene mutations cause various skin and hair disorders, but new research offers hope for future treatments.

Certain genetic variants increase the risk of aggressive prostate cancer.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Over-expression of Sp2 can lead to cancer by preventing proper stem cell differentiation.

MFN2 mutations cause mitochondrial problems, unusual fat distribution, and low leptin despite high body fat.